The gradual and sustained weight loss is only proven when using the standard therapeutic doses
At JosephCareRX, we incorporate GLP-1-based medications as part of individualized treatment plans for patients struggling with obesity, type 2 diabetes, or metabolic syndrome
Weeks 13-24 (Approaching or Reaching Maintenance Dose): As you approach or reach your maintenance dose (timing varies by productWegovy typically by week 17, others on different schedules), the medication's effects stabilize
GLP-1 medications can be costly, so its important to discuss the cost and insurance coverage with us during your visit
However, the potential for delaying or preventing the progression of T2DM in patients treated with GIP and GLP-1 remains uncertain, as there is currently no definitive evidence from human studies demonstrating that enhanced incretin activity directly affects -cell mass or alters the progressive loss of insulin secretory capacity in humans
doi: 10.1038/nrendo.2015.7 30 SudoSSudoMSimonsCTDessirierJMCarstensE